These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2844873)

  • 21. A multicenter, randomized, double-blind, placebo-controlled trial of pimobendan, a new cardiotonic and vasodilator agent, in patients with severe congestive heart failure.
    Katz SD; Kubo SH; Jessup M; Brozena S; Troha JM; Wahl J; Cohn JN; Sonnenblick EH; LeJemtel TH
    Am Heart J; 1992 Jan; 123(1):95-103. PubMed ID: 1729854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasodilators and inotropic agents in the treatment of congestive heart failure.
    Francis GS
    Semin Nephrol; 1994 Sep; 14(5):464-78. PubMed ID: 7997651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Do vasodilators help in chronic heart failure?].
    Slany J
    Wien Klin Wochenschr; 1987 Mar; 99(5):139-44. PubMed ID: 2883777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical aspects of differential drug therapy of chronic heart failure].
    Erdmann E; Beuckelmann D; Böhm M; Schwinger HG
    Z Kardiol; 1992; 81 Suppl 4():97-103. PubMed ID: 1290310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiologic determinants of survival in congestive heart failure. The survival hypothesis: how small uncontrolled studies should influence the design of large-scale clinical trials.
    Francis GS
    Circulation; 1987 May; 75(5 Pt 2):IV74-9. PubMed ID: 3568319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term strategies in the management of heart failure: looking beyond ventricular function and symptoms.
    Packer M
    Am J Cardiol; 1992 Jun; 69(18):150G-154G. PubMed ID: 1626488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug therapy of congestive heart failure].
    Sasayama S
    Nihon Naika Gakkai Zasshi; 1997 Sep; 86(9):1770-7. PubMed ID: 9410998
    [No Abstract]   [Full Text] [Related]  

  • 28. [Trends in pharmacological treatment of congestive heart failure].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in the management of chronic heart failure.
    Chatterjee K
    Prim Care; 1985 Mar; 12(1):117-42. PubMed ID: 3846305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy of chronic heart failure with vasodilator agents].
    Zähringer J; Schultheiss HP
    Internist (Berl); 1986 May; 27(5):315-21. PubMed ID: 3015822
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of congestive heart failure. Pathophysiologic and pharmacologic concepts.
    Goldsmith SR
    Postgrad Med; 1987 Jun; 81(8):257-66, 268. PubMed ID: 3035525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathophysiological mechanisms underlying the adverse effects of calcium channel-blocking drugs in patients with chronic heart failure.
    Packer M
    Circulation; 1989 Dec; 80(6 Suppl):IV59-67. PubMed ID: 2688986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure.
    Packer M
    J Am Coll Cardiol; 1992 Jul; 20(1):248-54. PubMed ID: 1351488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathophysiology of chronic heart failure.
    Francis GS
    Am J Med; 2001 May; 110 Suppl 7A():37S-46S. PubMed ID: 11334774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy for systolic dysfunction: a review of randomized clinical trials.
    Gheorghiade M; Benatar D; Konstam MA; Stoukides CA; Bonow RO
    Am J Cardiol; 1997 Oct; 80(8B):14H-27H. PubMed ID: 9372994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chronic heart failure: effect and evaluation of therapy with positive inotropic substances].
    Thormann J; Kramer W; Dieterich HA
    Herz; 1990 Jun; 15(3):190-201. PubMed ID: 2198220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium-channel blockade in the management of severe chronic congestive heart failure: a bridge too far.
    Packer M; Kessler PD; Lee WH
    Circulation; 1987 Jun; 75(6 Pt 2):V56-64. PubMed ID: 3552317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contrasting hemodynamic responses in severe heart failure: comparison of captopril and other vasodilator drugs.
    Packer M; Medina N; Yushak M
    Am Heart J; 1982 Nov; 104(5 Pt 2):1215-23. PubMed ID: 6753552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Exercise test in the evaluation of the efficacy of drug therapy].
    Febo O; Cobelli F
    Ital Heart J Suppl; 2000 Mar; 1(3):393-9. PubMed ID: 10815269
    [No Abstract]   [Full Text] [Related]  

  • 40. Vasodilator therapy for congestive heart failure. Lessons from mortality trials.
    Groden DL
    Arch Intern Med; 1993 Feb; 153(4):445-54. PubMed ID: 8435024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.